Physician profile
Gregory G Bashian
NPI 1487854311
$360,889.25
in general payments reported to CMS, 2019-2025
35 companies · $8,230 in 2025
The $8,230 reported for 2025 was more than what 76% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $59K · 2021: $117K · 2022: $105K · 2023: $21K · 2024: $8,343 · 2025: $8,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Consulting Fee: $14K · Food and Beverage: $6,397 · Travel and Lodging: $2,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,314.00 |
| Consulting Fee | $14,087.83 |
| Food and Beverage | $6,397.23 |
| Travel and Lodging | $2,314.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $242,370.22 | 2019-2024 | |
| Abbott Laboratories | $46,358.76 | 2019-2025 | Advisor, Tacticath Ablation Catheter, Sensor Enabled, Ensite |
| Pfizer INC. | $35,369.40 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $23,186.16 | 2019-2023 | Camzyos, Eliquis |
| Medtronic, INC. | $5,806.60 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Pulseselect |
| Boston Scientific Corporation | $4,832.84 | 2019-2025 | Farapulse, Watchman Flx, Cds - Mct/Cem Monitoring |
| Biosense Webster, INC. | $1,065.84 | 2020-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $379.17 | 2019-2023 | Lifevest |
| Philips North America LLC | $223.34 | 2020-2025 | Igt Devices Undivided, Ecc Solutions |
| Impulse Dynamics (USA) INC. | $174.48 | 2021 | |
| Medtronic Vascular, INC. | $164.13 | 2019 | |
| Novo Nordisk INC | $151.80 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Volta Medical INC | $99.55 | 2024 | Vx1 |
| Abiomed | $85.00 | 2021 | |
| Edwards Lifesciences Corporation | $63.48 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $53.90 | 2022-2024 | |
| Biotronik INC. | $53.81 | 2020 | |
| Inspire Medical Systems, INC. | $47.90 | 2023-2025 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $41.71 | 2022-2024 | Wainua |
| Amgen INC. | $39.37 | 2021-2023 | Repatha |
| Kiniksa Pharmaceuticals International, Plc | $38.03 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.73 | 2019-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $30.56 | 2022-2023 | Xarelto |
| Terumo Medical Corporation | $27.99 | 2025 | Azur Cx Detachable |
| Astellas Pharma US INC | $26.14 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $25.92 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.06 | 2024 | Evkeeza |
| Esperion Therapeutics, INC. | $22.25 | 2021 | |
| Shockwave Medical, INC | $20.32 | 2025 | |
| Heartflow, INC. | $17.91 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.74 | 2025 | |
| Kiniksa Pharmaceuticals, Ltd. | $16.13 | 2023 | Arcalyst |
| Ekos Corporation | $14.96 | 2019 | |
| Medtronic USA, INC. | $11.05 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Bashian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.